5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma

B. H. Kushner, S. Modak, K. Kramer, E. M. Basu, S. S. Roberts, N. Kv Cheung

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of '5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences